Hadassah

Hadassah: Renowned in Noninvasive Removal of Kidney Stones

Wednesday, Jan 9 2013

One of the first hospitals in the world to acquire a lithotripter--which revolutionized the elimination of kidney stones with noninvasive shock wave therapy—the Hadassah Medical Center today houses the largest Kidney Stone Treatment Center in Israel.

Since 1985 when Hadassah began treating patients with shock wave lithotripsy, the Center has retired its first unit, replacing it in August 2010 with the more sophisticated Dornier Gemini lithotripter. The new machine causes less discomfort to patients and requires milder sedation. Where previously patients needed to be placed in a special bath for the treatment, they now undergo the hour procedure fully clothed, lying on a bed.

Hadassah's lithotripsy patients have ranged from a five-year-old girl who had a large stone in her right kidney, to a middle-aged woman with a renal pelvis stone, to a 107-year-old man who developed a stone in the upper part of his ureter. The middle-aged woman had been originally scheduled for surgery at another hospital to remove the stone, but decided to seek a second opinion at Hadassah. While Dr. Duvdevani, Director of Hadassah's Lithotripsy and Endo-Urology units, agreed that the size and location of the stone did make the woman a candidate for surgery, he suggested that she try one lithotripsy treatment to see if surgery could be avoided. Dr. Duvdevani dilated her ureter by inserting a stent, which also created an easier exit for the stone fragments. The lithotripsy proved successful in shattering the stone, which within four weeks passed out normally through her urine.

Dr. Duvdevani serves on a seven-member international committee that determines which medical centers throughout the world will be authorized to conduct fellowships in endo-urology, thereby shaping this specialty for the future. The Endo-Urological Society has authorized Hadassah to be the first non-American/non European Medical Center to conduct fellowships in endo-urology. The first fellow to train at Hadassah is a physician from India.

Click here for more news from Hadassah Medical Organization>>

Comments

No comments yet.
First Name
Email
Comment
Enter this word:

Related Stories

alt_text

Wednesday, Nov 30 2016

Hadassah Teams Up with Spinal Cord Institute to Study Outcomes of Traumatic Injuries

The medical interventions and outcomes for Israelis with a spinal cord injury (SCI) will now be captured in the Rick Hansen SCI Registry (RHSCIR), thanks to the November 16th launch of a partnership between the Hadassah Medical Organization and the Rick Hansen Institute (RHI), a Canadian-based not-for-profit organization named after the paralympic athlete who suffered a severe spinal cord injury following a car accident.

READ MORE ›
alt_text

Thursday, Nov 17 2016

A Birthday Party in Hadassah’s PICU: Helping a Four-Year-Old Recover

Yehoshua "Shuki" Pepper was crossing a Jerusalem street with an older sibling when a car ran him over. He was rushed to Hadassah Hospital Ein Kerem's Pediatric Intensive Care Unit in fair condition, but he wasn't speaking and subsequent MRIs of his head injury were worrisome.

READ MORE ›
alt_text

Thursday, Nov 17 2016

Ethiopian Pre-Nursing Students: On the Way to Fulfilling a Dream

“I know that some people are fine with looking at a screen all day, but I know I need the human touch--to work with people. I want to be a nurse, " relates Sarah Talala, one of the 18 students of Ethiopian background who were given the opportunity to take a course which enabled them to advance to pre-academic studies at the Hebrew University and then on to nursing school at the Hadassah-Hebrew University Henrietta Szold School of Nursing.

READ MORE ›
alt_text

Monday, Nov 14 2016

Granalix BioTechnologies Introduces Food Additive to Protect Against Neurodegenerative Disease

Granalix BioTechnologies, whose founder and Chief Executive Officer is Hadassah Medical Organization Experimental Neurologist Prof. Ruth Gabizon, has launched a food supplement containing pomegranate oil that has proven to protect against neurodegenerative diseases in pre-clinical models.

READ MORE ›

Contact Us

40 Wall Street

New York, NY 10005

support@hadassah.org

More ›

Membership Questions

membership@hadassah.org

(800) 664-5646

Donation Questions

donorservices@hadassah.org

(800) 928-0685

Missions Department

missions@hadassah.org

(800) 237-1517

Show More